VEBANVIBART

UNII:	5TL7E5D6E6
Type:	INGREDIENT SUBSTANCE
Formula:
Preferred Substance Name:	VEBANVIBART
GSRS Full Record:	5TL7E5D6E6 i

2937321-40-7
H-gamma1 heavy chain Homo sapiens (1-455) [VH (Homo sapiens IGHV1-69*01 (88.8%) -(IGHD) -IGHJ4*01 (85.7%) S128>A (125), CDR-IMGT [8.8.18] (26-33.51-58.97-114)) (1-125) -Homo sapiens IGHG1*01, G1m17,1, CH1 K120, CH3 D12, L14, G1v21 CH2 Y15.1, T16, E18 (CH1 K120 (222) (126-223), hinge 1-15 (224-238), CH2 M15.1>Y (260), S16>T (262), T18>E (264) (239-348), CH3 D12 (364), L14 (366) (349-453), CHS (454-455)) (126-455)], (228-215')-disulfide with L-kappa light chain Homo sapiens (1'-215') [VKAPPA (Homo sapiens IGKV1-33*01 (95.8%) -IGKJ2*01 (91.7%), CDR-IMGT [6.3.10] (27'-32'.50'-52'.89'-98')) (1'-108') -Homo sapiens IGKC*01 (100%), Km3 A45.1 (154'), V101 (192') (109'-215')]; dimer (234-234'':237-237'')-bisdisulfide, produced in a cell line from Chinese hamster ovary (CHO) cells, derived from the cell line CHO-K1, glycoform alfa
Immunoglobulin G1 [260-tyrosine,262-threonine,264-glutamic acid], anti-(severe acute respiratory syndrome coronavirus 2 spike glycoprotein receptor-binding domain) (human monoclonal SA55 γ1-chain), disulfide with human monoclonal SA55 κ-chain, dimer
SA-55
SA55
Vebanvibart
immunoglobulin G1-kappa, anti-[severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike (S) protein, receptor binding domain (RBD)], Homo sapiens monoclonal antibody (vebanvibart)
vebanvibart [INN]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

VEBANVIBART

Synonyms and Mappings

Resources